Authors
Rongxin Liu, Miao Zhang, Yusen Zhao, Haijie Dong, Hongzong Si, Yusheng Niu
Published in
Current pharmaceutical design. Nov 04, 2026. Epub Nov 04, 2026.
Abstract
This study computationally explores the polypharmacological mechanisms of Jiangtang Pill (JTP) in treating Type 2 Diabetes Mellitus (T2DM) using an integrated in silico approach.
Active compounds of JTP and predicted pharmacological targets were extracted from databases. Protein-protein interaction networks identified core hubs, which were intersected with DEGs from a T2DM transcriptomic dataset (GSE15932). Functional mechanisms were evaluated via GO and KEGG analyses. Immune infiltration was assessed using CIBERSORT. Molecular docking and 100-ns Molecular Dynamics (MD) simulations were performed to evaluate the predicted binding interactions and dynamic behavior of key ligand-protein complexes.
AKT1, MAPK3, STAT3, and TNF emerged as candidate targets supported by the integrated network and transcriptomic analyses. Functional enrichment highlighted the PI3K-Akt, AGE-RAGE, and MAPK pathways. CIBERSORT analysis indicated a lower estimated abundance of CD4+ memory activated T cells in T2DM, which was inversely associated with the expression of selected targets. The 100-ns MD simulations showed that the four ligand-protein complexes remained dynamically associated throughout the trajectories, with distinct RMSD, RMSF, compactness, and hydrogen-bonding profiles for β-sitosterol and kaempferol.
By integrating network pharmacology, clinical transcriptomics, and structural analyses, this study supports a hypothesis that JTP may influence metabolic and immune-related pathways involved in T2DM.
These findings provide a testable computational framework for the potential multi-target actions of JTP and warrant further experimental validation.
PMID:
43021767
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0